Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Liefhebber JMP"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liefhebber JMP; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands., Brasser G; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands., Spronck EA; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands., Ottenhoff R; Amsterdam UMC, Amsterdam 1105 AZ, the Netherlands., Paerels L; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands., Ferraz MJ; Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, the Netherlands., Schwarz LK; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands., Efthymiopoulou N; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands., Kuo CL; Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, the Netherlands.; VIB, 9052 Ghent, Belgium., Montenegro-Miranda PS; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands.; VectorY Therapeutics B.V., Amsterdam 1098 XH, the Netherlands., Evers MM; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands., Aerts JMFG; Leiden Institute of Chemistry, Leiden University, Leiden 2333 CC, the Netherlands., Liu YP; uniQure biopharma B.V., Amsterdam 1105 BP, the Netherlands.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2024 Nov 12; Vol. 32 (4), pp. 101375. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2024).
Autor:
Zancanella V, Vallès A, Liefhebber JMP, Paerels L, Tornero CV, Wattimury H, van der Zon T, van Rooijen K, Golinska M, Grevelink T, Ehlert E, Pieterman EJ, Keijzer N, Gerardus Princen HM, Stokman G, Liu YP
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2024 Apr 18; Vol. 35 (2), pp. 102189. Date of Electronic Publication: 2024 Apr 18 (Print Publication: 2024).
Autor:
Zancanella V; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Vallès A; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Liefhebber JMP; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Paerels L; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Tornero CV; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Wattimury H; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., van der Zon T; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., van Rooijen K; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Golinska M; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Grevelink T; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Ehlert E; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands., Pieterman EJ; TNO Metabolic Health Research, Sylviusweg 71 2333 BE Leiden, The Netherlands., Keijzer N; TNO Metabolic Health Research, Sylviusweg 71 2333 BE Leiden, The Netherlands., Princen HMG; TNO Metabolic Health Research, Sylviusweg 71 2333 BE Leiden, The Netherlands., Stokman G; TNO Metabolic Health Research, Sylviusweg 71 2333 BE Leiden, The Netherlands., Liu YP; uniQure biopharma B.V., Department of Research and Development, 1105 BP, Amsterdam, The Netherlands.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Apr 07; Vol. 32, pp. 454-467. Date of Electronic Publication: 2023 Apr 07 (Print Publication: 2023).